Neutralization heterogeneity of United Kingdom and South-African SARS-CoV-2 variants in BNT162b2-vaccinated or convalescent COVID-19 healthcare workers

Archive ouverte

Marot, Stéphane | Malet, Isabelle | Leducq, Valentin | Abdi, Basma | Teyssou, Elisa | Soulie, Cathia | Wirden, Marc | Rodriguez, Christophe | Fourati, Slim | Pawlotsky, Jean-Michel | Boutolleau, David | Burrel, Sonia | Calvez, Vincent | Marcelin, Anne-Geneviève | Jary, Aude

Edité par CCSD ; Oxford University Press (OUP) -

International audience. There are concerns about neutralizing antibodies (NAbs) potency against SARS-CoV-2 variants. Despite decreased NAb titers elicited by BNT162b2-vaccine against VOC202012/01 and 501Y.V2 strains, 28/29 healthcare workers (HCW) had a NAb titer ≥1:10. In contrast, six months after COVID-19 mild-forms, only 9/15 (60%) of HCW displayed detectable NAbs against 501Y.V2 strain.

Suggestions

Du même auteur

Evolution of viral quasispecies during SARS-CoV-2 infection

Archive ouverte | Jary, Aude | CCSD

International audience. Objectives: Studies are needed to better understand the genomic evolution of the recently emerged severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This study aimed to describe ge...

The 501Y.V2 SARS-CoV-2 variant has an intermediate viral load between the 501Y.V1 and the historical variants in nasopharyngeal samples from newly diagnosed COVID-19 patients

Archive ouverte | Teyssou, Elisa | CCSD

International audience

Rapid decline of neutralizing antibodies against SARS-CoV-2 among infected healthcare workers

Archive ouverte | Marot, Stéphane | CCSD

International audience. There are only few data concerning persistence of neutralizing antibodies (NAbs) among SARS-CoV-2-infected healthcare workers (HCW). These individuals are particularly exposed to SARS-CoV-2 i...

Chargement des enrichissements...